Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

New BCG-Unresponsive NMIBC Treatment Review Study

European Urology Oncology Available online 15 November 2024 David D...

November 21, 2024

V.TLT

RE:This is TLT

You are certainly not alone BlueFranky. Maybe someone could create a TLT...

November 17, 2024

V.TLT

Sonodyhamic Therapy Study Cites Advantages of Rutherrin

The following study of Sonodynamic Therapy notes how PDT with Rutherrin makes...

November 14, 2024

V.TLT

Avian influenza: 1st human case detected in B.C.

June 4:   Theralase Technology Effective in Virus Inactivation...

November 13, 2024

V.TLT

RE:RE:RE:J and J Tar 200 claiming a high CR % for NMIBC

There is also the safety issue to consider. They reported that 9.4% of...

November 9, 2024

V.TLT

RE:RE:Here we are again

"Presumeably, having the pre-BTD rejected would be s material...

November 6, 2024

V.TLT

RE:RE:RE:RE:Preliminary Breakthrough Therapy Designation (BTD) Advice

Hi wildbird1 - like you I am convinced Ruvidar PDT will soon  get BTD...

November 3, 2024

V.TLT

RE:RE:Preliminary Breakthrough Therapy Designation (BTD) Advice

Hi Maxcitrac - preliminary BTD advice is a useful tool but it's up to...

November 1, 2024

V.TLT

Preliminary Breakthrough Therapy Designation (BTD) Advice

The FDA BTD FAQ site makes it clear that preliminary BTD advice is advisory...

November 1, 2024

V.TLT

Phew! Looks like we're going to make it through 2024...

The 2024 Biotech Graveyard The 2023 Biotech Graveyard The 2022 Biotech...

October 31, 2024

V.TLT

RE:RE:RE:Just asking for numbers.

I've wondered about that too. But we are better than the approved...

October 29, 2024

V.TLT

RE:Just asking for numbers.

The FDA advised Theralase that a BTD application would have a better chance...

October 29, 2024

V.TLT

RE: Iridium study

I think Theralase does have the right to use them. Dr. McFarland's patent...

October 25, 2024

V.TLT

New Paper by Dr. McFarland

Dr. McFarland and team are now working on Iridium based photosensitizers...

October 25, 2024

V.TLT

RE:RE:RE:GL All

Amen, zombize. zombize wrote: I bought at the same time because for no other...

October 24, 2024

V.TLT

RE:RE:RE:RE:RE:Today marks 2 weeks (or longer)

In July 2023 Theralase had their first pre-BTD meeting with the FDA. At that...

October 19, 2024

V.TLT

RE:RE:RE:Today marks 2 weeks (or longer)

Hi TommyNickels - I doubt that the delay was caused by the need for an...

October 19, 2024

V.TLT

RE:CANCER CENTRE OPENING TODAY LARGEST IN CANADA

Thanks irelandon5. I wonder if it's too late in the trial for Theralase...

October 17, 2024

V.TLT

RE:Best in class 2and 3 year data

That's right! We are headed for an absolute 21.5 %  CR rate at 3...

October 13, 2024

V.TLT

$12 to access this article for 48 hours

From Concept to Cure: The Road Ahead for Ruthenium-Based Anticancer Drugs...

October 11, 2024

Featured Company